InvestorsHub Logo
icon url

sab63090

08/17/20 3:57 PM

#32948 RE: boozeman #32946

@boozeman

Yeah, I agree....will try to avoid other stocks on this board...needed some good news to offset the boring action here!

Nothing has really worsened here in the last few days...stock is working off that long, long trip down, turned and is basically testing whether it will hold above the 200 day sma and (so far) it has held up.

What is needed is strong buying interest developing, not evident right now. Where is our Whale?

Good luck...
icon url

MyAlias1

08/17/20 6:00 PM

#32953 RE: boozeman #32946

Yeah I don't get the lack of anticipation ...

1. Several Cytokines have been approved in cancer immunotherapy.
2. National Institute of Health has identified those required to reject tumors.
3. Multikine does not have the safety problem that several cytokine based trials have run into.
4. Phase 2 10.5% of patients no remaining cancer cells after 3 wks Multikine.
5. Phase 2 remaining patients had ~50% average reduction in number of cancer cells after 3 wks Multikine.
6. Phase 2 Pathology
7. Phase 2 CD4/CD8 ratio

I understand that a small cap has had its share of issues and then some getting to this point and the binary nature of the data. It seems odd to me to think that all bets have been placed.